Clinical Trials
2 trialsNCT05984888 2025-10-03
MIND-BC
Ohio State University Comprehensive Cancer Center
Phase NA Recruiting
NCT06770296 2025-01-13
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study
The First Affiliated Hospital with Nanjing Medical University
Phase 1 Recruiting